insitro Receives $25 Million in Milestone Payments from Bristol Myers Squibb for the Achievement of Discovery Milestones and the Selection of First Novel Genetic Target for ALS Read More
insitro and Lilly Enter Strategic Agreements to Advance Novel Treatments for Metabolic Diseases Read More
insitro Hires AI and Machine Learning Visionary, Emily Fox, Ph.D., as Senior Vice President of AI/ML Read More
Leading Clinical Research Innovator, Amy Abernethy, M.D., Ph.D., Joins insitro Board of Directors Read More
insitro Appoints Philip Tagari, Industry-Leading Scientist and Drug Hunter, as Chief Scientific Officer Read More
insitro and Genomics England Announce Partnership to Provide Multimodal Search Capabilities and Empower Data Exploration and Derivation of Novel Insights Read More
insitro Announces Leadership Team Expansion to Support Advancement of Machine Learning Enabled Drug Discovery and Development Efforts Read More
